Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
Denis Roy(Montreal Heart Institute), Albert L. Waldo(Case Western Reserve University), Gilles O’Hara(Institut universitaire de cardiologie et de pneumologie de Québec), Bernard Thibault(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute), Martial G. Bourassa(Montreal Heart Institute), A. John Camm(St George's Hospital), Lynne W. Stevenson(Vanderbilt University Medical Center), Stanley Nattel(Montreal Heart Institute), Peter G. Guerra(Montreal Heart Institute), Stuart J. Connolly(Population Health Research Institute), Paul Dorian(St. Michael's Hospital), William G. Stevenson(Vanderbilt University Medical Center), Alfred E. Buxton(Rhode Island Hospital), Ole Dyg Pedersen(Bispebjerg Hospital), Marc Dubuc(Montreal Heart Institute), J. Malcolm O. Arnold(London Health Sciences Centre), Jean‐Lucien Rouleau(Montreal Heart Institute), Jean‐Yves Le Heuzey, Jean Lambert(Montreal Heart Institute), Bramah N. Singh(United States Department of Veterans Affairs), D. George Wyse(Libin Cardiovascular Institute of Alberta), Mario Talajic(Montreal Heart Institute), Kerry L. Lee(Clinical Research Institute), Stefan H. Hohnloser(Goethe University Frankfurt)
Cited by 1,578
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k